BENITEC BIOPHARMA

In News

Evercore ISI initiates Benitec BioPharma stock coverage at outperform - Investing.com

Investing.com - May 12, 2026

BNTC Initiates Coverage On Benitec Biopharma -- Rating Set to Ou - GuruFocus

GuruFocus - May 12, 2026

Rare swallowing disease study posts 24-month follow-up at gene therapy meeting - Stock Titan

Stock Titan - Apr 28, 2026

Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®

CGTLive® - Apr 19, 2026

Hedge funds owners may consider drastic measures as Benitec Biopharma Inc.'s (NASDAQ:BNTC) recent US$60m drop adds to long-term losses - simplywall.st

simplywall.st - Feb 14, 2026

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Yahoo Finance

Yahoo Finance - Feb 14, 2026

Benitec Biopharma Announces Oral Presentation of Interim - GlobeNewswire

GlobeNewswire - Apr 28, 2026

Benitec Biopharma Stock (BNTC) Opinions on $100M Stock Offering - Quiver Quantitative

Quiver Quantitative - Nov 11, 2025

Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade - Seeking Alpha

Seeking Alpha - Jan 31, 2026

Mintz Advises on Benitec Biopharma’s $80 Million Follow-On Offering and Concurrent $20 Million Registered Direct Offering - Mintz

Mintz - Nov 12, 2025

Jerel A. Banks, MD, PhD, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®

CGTLive® - Mar 13, 2026

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference - Yahoo Finance

Yahoo Finance - Mar 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment